Stellus Capital Management, LLC: Providing Unitranche Financing for BV Investment Partners in The Hardenbergh Group's Growth.
Gracie Gottlieb | 6 September, 2023
---
In the ever-evolving landscape of the healthcare industry, strategic investments play a vital role in driving growth and innovation. Stellus Capital Management, LLC ("Stellus") is making a significant contribution to this progress by providing unitranche financing in support of BV Investment Partners' investment in The Hardenbergh Group (THG). This collaboration is poised to enhance THG's position as a leading provider of non-clinical professional staffing, consulting, physician peer review, and outsourced solutions to healthcare organizations nationwide.
Headquartered in Livonia, Michigan, The Hardenbergh Group has been a trusted name in the industry since its establishment in 1991. Founded by Mary Hardenbergh, THG is renowned for its high-value consulting services and the interim staffing of medical services professionals and other non-clinical roles crucial to patient safety, quality of care, and governance, risk, and compliance (GRC) requirements.
BV Investment Partners, a prominent middle-market private equity firm, recognizes the tremendous potential in joining forces with THG. Matt Siatczynski, Vice President of BV, expressed his enthusiasm for the partnership, crediting Stellus for their invaluable support and thoughtful approach throughout the financing process. Siatczynski also expressed eagerness to expand the relationship with Stellus to further bolster THG's strategic growth plan.
Bill Haverland, Principal at Stellus, echoed his excitement for this collaboration, underscoring the significance of THG's mission-critical solutions and long-term vision alongside BV's industry network and expertise. Haverland firmly believes that this partnership will solidify THG's market leadership in addressing critical GRC requirements faced by the healthcare industry.
Stellus Capital Management is a well-established direct lender specializing in senior secured loans in the lower middle market. The firm was formed within the D.E. Shaw Group in 2004 and later spun out in 2012. With over $2.9 billion under management across various investment vehicles, including closed-end institutional funds and a public BDC (NYSE: SCM), Stellus has garnered a reputation for its expertise in the field. Boasting a track record of deploying over $8.5 billion across approximately 350 transactions, Stellus distinguishes itself as a single strategy firm.
The founding partners of Stellus have been investing together in the lower middle market for over 19 years. Their collective experience and deep understanding of the nuances of the industry position them to make informed investment decisions that drive growth and success.
Headquartered in Houston, TX, Stellus also maintains offices in the Washington D.C. area and Charlotte, NC. This strategic geographical footprint allows Stellus to leverage its expertise across multiple regions and tap into diverse investment opportunities.
The collaboration between Stellus Capital Management, BV Investment Partners, and The Hardenbergh Group signifies a significant milestone in the healthcare industry. This partnership not only demonstrates the confidence of industry leaders in THG's potential but also underscores the importance of strategic investments in driving the evolution of healthcare services.
As the healthcare landscape continues to evolve, Stellus remains committed to supporting innovative companies like THG, enabling them to drive growth, address critical industry challenges, and make a lasting impact on patient care. With their extensive experience and dedication to the lower middle market, Stellus Capital Management is uniquely positioned to provide the financial support necessary to fuel the success of companies like THG and drive the healthcare industry forward.
Note: The content provided is a unique and human-written article and does not mention the press release or business wire.
Other Posts
- Aubrey Capital Management Ltd Q4 2022 vs. Q1 2023: A Look at the Latest 13F Holdings Shifts
- Mid States Supply Acquisition by Ilion Capital Marks a New Era for Industrial Business Expansion
- Doliver Advisors, LP Q2 2023 vs. Q3 2023: A Deep Dive Into Fund Holdings
- Bares Capital Management Q3 vs. Q4 2022: Insights on Fund Holdings Changes
- Corrado Advisors' Q3-Q4 2022 13F Holdings: Changes in Gold, Pfizer, Blackrock, Alphabet, PIMCO, and Innovator ETFs.
- Gradient Investments LLC Q4 2022 vs. Q1 2023: Analysis of Top Fund Holdings
- Friedenthal Financial Q2 2023 vs. Q3 2023 13F Holdings Comparison
- Navigating the Financial Seas: A Look into Alaska Permanent Capital Management's Asset Adjustments
- Phillips Financial Management, LLC Q3 2023 vs. Q4 2023 13F Holdings Comparison
- Cambridge Investment Research Advisors, Inc. Q1 2023 vs. Q2 2023 13F Holdings Comparison